Biofilms are microbial derived sessile communities characterized by cells that are irreversibly attached to a substratum, or to each other, and embedded in a matrix of extracellular polymeric substances that they have produced [1] . Such micro-organisms exhibit an altered phenotype with respect to growth rate and gene transcription [2] . Biofilms forming on implanted medical devices are problematic as the extra cellular matrix exported by the micro-organisms along with the changes in their physiology result in the requirement to remove the device to effect a cure [3, 4] .
Pseudomonas aeruginosa (P. aeruginosa) is a human opportunistic pathogen that colonizes biotic and abiotic surfaces and has emerged as a primary source of nosocomial infections [5] , especially in cystic fibrosis sufferers and immuno-compromised patients [6] . The bacterium almost never infects uncompromised tissues, yet there is hardly any tissue that it cannot infect if the tissue defences are compromised in some manner, such as in severe burns sufferers [7] . In the United States, P. aeruginosa ranked first among all nosocomial pathogens related to pneumonia in intensive care units reported to the National Nosocomial Infection Surveillance System [8] .
Pseudomonas sp. in general and P. aeruginosa, specifically, has resistance to antibiotics including aminoglycosides and quinolones, and this is steadily increasing [9] . The mechanisms of biofilm formation are poorly understood and effective prevention and therapeutic strategies still need to be developed for device-associated infections. Treatment with antibiotics can slow down biofilm progression by eliminating planktonic cells and interfering with biofilm metabolism [10] , but complete removal is rare. Other eradication methods that have been employed include prevention of initial attachment of bacterial cells by constructing materials into which antimicrobial agents have been incorporated [10] and minimizing biofilm formation by the disruption of quorum-signalling molecules, allowing for improved inactivation and removal [11] .
Glass polyalkenoate cements (GPCs), formed by the reaction between an ion-leachable glass and an aqueous solution of polyacrylic acid (PAA) [12] , are both antibacterial and cariostatic [13] ; properties related to their ability to release beneficial amounts of therapeutic ions [14, 15] .
Studies have shown that inhibition of bacterial growth correlates with zinc (Zn 2+ ) and silver (Ag + ) ion release from novel GPCs [16, 17] . Zn 2+ has been shown to inhibit multiple activities in the bacterial cell including glycolysis, transmembrane protein translocation and acid tolerance [18] . It also influences pH, which rises throughout glycolysis via the action of Zn 2+ on the bacterial cell wall and therefore leaves an excess of OH -that results in a favourable bioactive response [19] . The minimum Zn 2+ concentration required for P. aeruginosa inhibition is 6.02×10 -4 µg/ml [20] and 8µg/ml for biofilm inhibition [21] . Ag + is also a known antibacterial agent [22, 23] . To have antimicrobial efficacy against P. aeruginosa bacteria, Ag + must be released in biocidal concentrations of 1.102×10 -6 µg/ml [24] and 5 µg/ml for biofilm inhibition [25] . Ag + avidly binds to negatively charged components in proteins and nucleic acids, thereby causing structural changes in bacterial cell walls, membranes and nucleic acids that affect viability [26] .
It is accepted that novel Zn-Ag-GPCs are antibacterial against a clinical isolate of P. aeruginosa [16] , but the objective of the work reported herein is to determine whether such a material can inhibit the proliferation of a biofilm forming from P. aeruginosa.
A glass (56.04SiO 2 , 32.76ZnO, 0.33Ag 2 O, Na 2 O10.87 mol%) was synthesized by mixing appropriate amounts of analytical grade reagents in a ball mill (1 h), then firing the mixture in a mullite crucible (1480°C, 1 h), prior to shock quenching into water. The resulting frit was ground down and all further work was undertaken on sub 25 μm particles. The GPC was prepared by mixing 0.5 g glass with 0.2 g PAA (Mw, 210,000, Ciba Specialty Polymers, Bradford, UK) and 0.25 ml distilled water on a clean glass plate with a dental spatula in ambient laboratory conditions. Cement constructs ( Figure 1 ) were produced by placing the cement into moulds (4 mmØ, 6 mm ht) and maturing in an oven (37˚C, 24 h). Ion release from the GPC was already reported [16] , but is included here (Figure 2 ) for completeness. In agreement with the literature [27] , the majority of Zn 2+ (1.5 ppm) and Ag + (0.2 ppm) release occurred in the first 24 hours. The literature reports a similar study using polymethylmethacrylate (PMMA) cement (VersaBond; Smith & Nephew, Memphis, TN, USA), where high absorbance rates, similar to those in the wells containing solely biofilm in this study, indicated that PMMA was unable to eliminate biofilm [28] . Therefore the reduction in absorbance in the wells that contained the novel Zn-Ag-GPC in this study indicates that the cement partially eliminated the biofilm present and prevented the formation of any more. Biofilm formation on medical devices has severe health consequences as it provides a sanctuary for bacteria, which are tolerant to both host defence mechanisms and antibiotic therapies. This study has shown that a novel Zn-Ag-GPC can inhibit such biofilm formation and partially reduce the levels of biofilm in vitro indicating that it may be possible to produce coatings or cements from this novel Zn-Ag glass that retard or partially inhibit biofilm formation from Ps. Aeruginosa.
